3136 results for «2658»
3136 results
Seeing is believing: predictable and durable treatment of mitral regurgitation across etiologies with the PASCAL platform
23 Nov 2021 – From PCR London Valves
Explore the clinical impact of the Edwards portfolio of transcatheter devices for mitral regurgitation treatment in this PCR London Valves 2021 session that you shouldn't miss if you want to attend case-based discussions that will analyze key PASCAL features to treat mitral regurgitation and to participate...
Miscellaneous - Paravalvular leak closure, PFO closure and LAA occlusion
21 Nov 2021 – From PCR London Valves 2021
Want to know more about the impact of baseline PFO anatomy on residual right to left shunt after transcatheter closure, transcatheter closure of paravalvular leak, or even percutaneous mitral paravalvular leak closure using CT planning? This PCR London Valves 2021 session is for you!
From TAVI to mitral and tricuspid - Applying evidence to expand patients' treatment options
21 Nov 2021 – From PCR London Valves 2021
Nowadays, there is an increasing range of treatment options as far as tricuspid and mitral regurgitations are concerned. Bernard Prendergast, Philipp Lurz, Fabien Praz and Maurizio Taramasso discuss the challenges and needs regarding mitral and tricuspid valve disease treatment. They also consider what is needed to...
TAVI access
21 Nov 2021 – From PCR London Valves 2021
Watch this series of videos from PCR London Valves 2021 for clinical outcomes after single access transfemoral transcatheter aortic valve implantation, to consider transcaval TAVI as a reliable alternative, to appreciate a fully percutaneous subclavian approach for TAVI, and much more!
Pushing boundaries in tricuspid therapy - The TricValve solution
22 Dec 2021 – From GulfPCR-GIM 2021
In this session, learn about the TricValve system in the treatment of severe TR and right heart disease, obtain insight from the experts with case scenarios, and understand how the TricValve Transcatheter Bicavel system can help patients with severe TR.
From TAVI to mitral and tricuspid - Applying evidence to expand patients' treatment options - Part 1 - Best long-term outcomes start with the first procedure
21 Nov 2021 – From PCR London Valves
In this session from PCR London Valve 2021 dedicated to TAVI, mitral, and tricuspid, let's examine the issues related to the lifetime patient journey faced by many patients, starting with an analysis of severe aortic stenosis: how to identify the most important factors when considering the...
PCR London Valves 2021 Hotlines / Late-Breaking Trials: bRIGHT, EXPAND, CHOICE-MI
21 Nov 2021 – From PCR London Valves
Real-world outcomes for tricuspid edge-to-edge repair, predictors of heart failure hospitalisation and its impact on clinical outcomes, one-year outcomes after TMVI... View part of the Late-Breaking Trials presented during PCR London Valves 2021.
The impact of the first transcatheter heart valve on the lifetime management of patients with aortic stenosis
18 May 2022 – From EUROPCR 2022
This session from EuroPCR 2022 will help you understand how the first bioprosthetic aortic valve may affect long-term outcomes of patients with aortic stenosis. Learn how to optimise their lifetime management and how to refine procedural steps during TAVI.
Redefining indications for drug-eluting balloons in complex PCI - The role of sustained limus release
18 May 2022 – From EuroPCR 2022
Thanks to this EuroPCR 2022 session, discuss how sustained limus release technology can broaden DEB indications, learn about the decision-making process on the use of DEB adjacent to DES in complex PCI, and review DEB specific implantation techniques to achieve optimal outcomes for the patient.
The right valve choice for TAVI patient longevity and durability
18 May 2022 – From EuroPCR 2022
Watch this session to learn about the impact of age and life expectancy on decision-making for TAVI, to become aware of the durability data of the current TAVI platform, and to revise contemporary implantation techniques and procedural goals for future TAVI-in-TAVI.
Transradial approach, from complex PCI to peripheral intervention
19 May 2022 – From EUROPCR 2022
Watch this session if you want to demonstrate how to optimise challenging coronary and peripheral cases using dedicated devices in transradial approach, to appreciate the value of transradial approach for complex PCI and carotid artery stenting and to acknowledge Ultimaster DES results in high bleeding risk patient...
The ability to transform coronary artery disease treatment: innovative nanotechnology-based sirolimus DES and DCB platforms
18 May 2022 – From EuroPCR 2022
Alexandre Abizaid, Marco Valgimigli, Fazila Malik, Luca Testa, Patrick W. Serruys, Damiano Regazzoli, Kumar Prathap, and Sandeep Basavarajaiah take turns in this session to discuss two innovative technologies: a stent platform with nanotechnology and a novel drug-coated balloon (DCB). These novel technologies both have unique features...
Mitral replacement: expanding patient options, even mitral annular calcification!
18 May 2022 – From EUROPCR 2022
The objectives of this session from EuroPCR 2022 are to provide the best pathway for mitral regurgitation management, to learn about early commercial TMVR experience and to discover treatment options for mitral annular calcification patients.
Left main and complex bifurcation PCI in high bleeding risk patients
View the life challenging case of a 90-year-old male patient with a very active lifestyle but hypertension, dyslipidemia, ex-smoker, who presented with left main bifurcation lesion, and appreciate the value of transradial approach for left main and complex bifurcation PCI, acknowledge Ultimaster DES results in bifurcations and high...
Tailored support for complex PCI and AMI with percutaneous mechanical circulatory support
17 May 2022 – From EuroPCR 2022
Watch this EuroPCR 2022 session, in which Javier Escaned, Florim Cuculi, and Norman Mangner present different cases, to learn how standard operating procedures including mechanical circulatory support improve outcomes in patients with complex coronary lesions, discuss new strategies to overcome ischemic reperfusion lesions using percutaneous mechanical circulatory support,...
Is DK Crush the optimal two-stent bifurcation strategy for left main PCI?
17 May 2022 – From EuroPCR 2022
In this EuroPCR 2022 session, follow the discussion around the recorded case of a 67-year-old non-smoking male patient who presented with chest pain on exertion typical of angina for one month, and learn how to optimally treat a severely calcified long lesion, understand how imaging can...
Double jeopardy: coronary disease in patients undergoing TAVI
17 May 2022 – From EuroPCR 2022
Through the presentation of real-life clinical cases, this session will allow you to discover the use of ALLEGRA for valve-in-valve TAVI, understand the management of coronary artery disease in TAVI patients, better detect when and how to protect coronary arteries during TAVI, or even learn how...
How to deal with calcified CTO
17 May 2022 – From EuroPCR 2022
In this dedicated session from EuroPCR 2022, listen to Gabriele Luigi Gasparini talk about procedural challenges and device selection for calcified CTO, while James Spratt looks at how to deal with long, calcified CTO, and Kambis Mashayekhi discusses problems and solutions in calcified CTO.
Leading clinical evidence while disrupting the mitral paradigm with clip therapy
17 May 2022 – From EuroPCR 2022
Watch this EuroPCR 2022 session with Nicole Karam, Stephan Baldus, Fabien Praz, Wolfgang Rottbauer, and Martin Swaans, and learn how the recent guidelines change the game in mitral disease management, how they can be implemented in practice, and what are the latest real-life clip data and...
Advances in renal denervation: from patient selection to procedure
17 May 2022 – From EuroPCR 2022
For this EuroPCR 2022 session, Felix Mahfoud is joined by David Kandzari, Rasha Al-Lamee, Flavio Ribichini, and Andrew Sharp to talk about renal denervation: hear real-life experiences and get the latest preclinical and clinical data on the long-term safety and efficacy of the radiofrequency renal denervation...
